Clinical Chemistry Analyzers Market - Global Forecast 2019


Posted September 2, 2016 by SPriyanka

This market is expected to grow at a CAGR of 5.52% between 2014 and 2019, to reach $11,728.01 million in 2019.

 
The “Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals) & by End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019” report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global clinical chemistry analyzers market along with the estimates and forecasts of the revenue and market share analysis.

Browse 76 market data tables and 138 figures spread through 194 pages and in-depth TOC on "Clinical Chemistry Analyzer Market

http://www.marketsandmarkets.com/Market-Reports/clinical-chemistry-analyzer-market-144027310.html
Early buyers will receive 10% customization on reports

The clinical chemistry analyzers market is segmented on the basis of products as analyzers, reagents and other products. Analyzers segment is further divided on the basis of sizes into four segments: Small Sized (400-800 Test/H), Medium Sized (800-1,200 Tests/H), Large Sized (1,200-2,000 Tests/H), Very large Sized (2,000 Tests/H). The analyzer product segment had the largest share of the clinical chemistry analyzers market in 2014, whereas the reagents product segment is expected to grow at the highest CAGR between 2014 and 2019. Reagents segment is further categorized into calibrators, controls, standards and other reagents. The reagents product segment is expected to grow at the highest CAGR between 2014 and 2019.

Download PDF brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=144027310

The application segments included in this report are tests such as, basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests. The basic metabolic panel tests segment had the largest share of the clinical chemistry analyzers market in 2014, whereas the lipid profile test segment is expected to grow at the highest CAGR between 2014 and 2019.

Request sample of this report@ http://www.marketsandmarkets.com/requestsample.asp?id=144027310

The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW).

Rise in number of lifestyle diseases, automation of laboratories will aid the growth of this market. The market is expected to be driven by increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation.

The major players in the clinical chemistry analyzers market include Roche Diagnostics (Switzerland), Danaher Corporation (U.S.), Abbott Diagnostics(U.S.), Siemens AG (Germany), Ortho-Clinical Diagnostics(U.S.), Thermo Fisher Scientific(U.S.), Randox Laboratories Ltd.(U.K.), ElitechGroup (France), Mindray (China),and Horiba(Japan).
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr. Rohan
Phone 1-888-600-6441
Business Address UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Country India
Categories Health
Tags clinical chemistry analyzers market
Last Updated September 2, 2016